The Scientist

» viruses, culture and developmental biology

Most Recent

image: Rethinking Herbal Medicine

Rethinking Herbal Medicine

By | September 10, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

21 Comments

image: Opinion: Learning from Each Other

Opinion: Learning from Each Other

By | September 7, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

2 Comments

image: The NSF Shake-Up

The NSF Shake-Up

By | September 7, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

2 Comments

image: Book Excerpt from <em>The Hour Between Dog and Wolf</em>

Book Excerpt from The Hour Between Dog and Wolf

By | September 5, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | September 1, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

0 Comments

image: Finding Injury

Finding Injury

By | September 1, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

0 Comments

image: Speaking of Science

Speaking of Science

By | September 1, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

1 Comment

image: A Story Biological

A Story Biological

By | September 1, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

0 Comments

image: Gifted in Science

Gifted in Science

By | September 1, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

1 Comment

image: Glass Shape Speeds Drinking

Glass Shape Speeds Drinking

By | August 31, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

31 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech